Hi Da Pu Ben! Huawei's entry into the traditional Chinese medicine industry is undoubtedly great news, and it has been widely spread in institutional circles. Huawei, the tech giant, is now working with TCM Data to develop a vertical model with the intention of using artificial intelligence to diagnose diseases and prescribe personalized TCM prescriptions to patients. This is not only a huge promotion of traditional Chinese medicine, but also a blessing for hundreds of millions of people.
Looking back at the history of A-shares, the concept of being related to Huawei has always attracted enthusiastic pursuit of funds. Thinking about the marriage between Huawei and the automobile industry, the stock price of Celis soared, more than tenfold. When Huawei's compatible technology was launched, it was also ten times larger**. Huawei's entry into the traditional Chinese medicine industry will undoubtedly lead a new wave of investment, and the market is looking forward to the emergence of a new ten-fold leader.
After an in-depth review and research, we have carefully read hundreds of recent research reports and found that only three TCM companies have in-depth cooperation with Huawei. These three companies will undoubtedly stand at the forefront of the industry and enjoy the technological dividends brought by Huawei. Investors, the opportunity is right in front of you, it's time to grasp this big **!
The first Yunnan Baiyao, together with Huawei, in the field of artificial intelligence, carried out comprehensive cooperation in drug research and development, and the state added 28.4 million shares in the third quarter to Huijin and social securityThe second Boshi shares, the former 4B minimally invasive abdominal surgery robot, the project research and development, at the leading level in China, the latter has an image-guided radiotherapy positioning systemThe last one has more potential to double, the first in China to sign a cooperation agreement with Huawei Cloud to jointly build a large model of traditional Chinese medicine, aiming to promote the innovation and upgrading of the traditional Chinese medicine industry, the profit in the third quarter not only exceeded that of last year, but also was social security**, and foreign capital joined forces to buy 70 million shares at the bottom, the current stock price is only about 10 yuan, and it may explode at any time at the end of the year, opening the main prestige.
I'll leave this company only to iron fans,Interested friends can click on my avatar, enter the homepage background and send me the number 178, remember that it is not the comment area, and the answer will be displayed automatically, I solemnly promise that all sharing is free, everyone can rest assured to check it, even if it is beneficial to you to make a reference.